RxDoctor Payments Data

Wayne Chung, MD

Otolaryngology · Brooklyn, NYNPI 1548423122

Payments from drug & device makers

$516in general payments, 2019–2025

Across 28 payments — averaging $18.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Optinose US, Inc.$210
  • Amgen$55
  • Circassia Inc.$39
  • Kaleo, Inc.$29
  • Regeneron Healthcare Solutions, Inc.$29
  • Sanofi$25
  • plus $127 from 7 others

What the payments were for

  • Food & beverage$516100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Optinose US, Inc.12$210
Amgen3$55
Circassia Inc.2$39
Kaleo, Inc.1$29
Regeneron Healthcare Solutions, Inc.2$29
Sanofi1$25
Takeda Pharmaceuticals U.S.A., Inc.1$23
GSK1$22
Eyevance Pharmaceuticals LLC1$21
Merck1$18
Alk-abello, Inc1$16
Glenmark Therapeutics Inc.1$15
Stryker1$13

How this compares

$516 in reported general payments places this provider in the 35th percentile of 701 otolaryngology providers in New York.

See all otolaryngology providers in New York

Medicare billing

Part B allowed, 2024
$65,283
Medicare patients
240
Services billed
579

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin29$1,957
Azelastine Hcl62$979
Ipratropium Bromide26$814
Dexamethasone Sodium Phosphate21$702
Fluticasone Propionate41$324
Omeprazole17$95
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$51

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Brooklyn

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →